Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CERE Cerevel Therapeutics Holdings

Watchlist
34.150
-0.400-1.16%
Close  01/31 16:00 ET
High
35.260
Open
34.540
Turnover
17.64M
Low
34.050
Pre Close
34.550
Volume
510.72K
Market Cap
5.34B
P/E(TTM)
Loss
52wk High
41.460
Shares
156.32M
P/E(Static)
Loss
52wk Low
19.860
Float Cap
2.33B
Bid/Ask %
100.00%
Historical High
46.161
Shs Float
68.18M
Volume Ratio
1.42
Historical Low
9.000
Dividend TTM
--
Div Yield TTM
--
P/B
8.85
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.75%
Amplitude
3.50%
Avg Price
34.542
Lot Size
1
Float Cap
2.33B
Bid/Ask %
100.00%
Historical High
46.161
Shs Float
68.18M
Volume Ratio
1.42
Historical Low
9.000
Dividend TTM
--
P/B
8.85
Dividend LFY
--
Turnover Ratio
0.75%
Amplitude
3.50%
Avg Price
34.542
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
CEO: Dr. N. Anthony Coles, M.D.
Market: NASDAQ
Listing Date: 06/05/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist